investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

The Development of First Time in Human (FTIH), Orally Bioavailable, Small Molecule Tankyrase Inhibitors for the Treatment of Cancer

Alan Ashworth

0 Collaborator(s)

Funding source

Wellcome Trust (WT)

Alan Ashworth

Institute of Cancer Research

London, United Kingdom

University of California, San Francisco

San Francisco, United States

Related projects

Rachael Rigby

Suppressor of cytokine signaling 3 is a key regulator of intestinal epithelial homeostasis

Colorectum

Janet E Dancey

NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Colorectum

Paul Sharpe

Wnt signalling and stem cell mobilisation in tissue injury repair

Colorectum

Ulrike Peters

Molecular Pathological Epidemiology of Colorectal Cancer

Colorectum

Ajit P Varki

Oligosaccharies of Normal and Malignant Cells

Colorectum

Douglas D Richman

Center for AIDS Research

Colorectum

Richard E Chaisson

The Johns Hopkins Center for AIDS Research (JHU CFAR)

Colorectum

Jane C Figueiredo

Adding Hispanics to Ongoing GWAS in Colorectal Cancer

Colorectum

Pathology

Martha L Slattery

miRNA and Colorectal Cancer: Associations with Tumor Phenotype and Survival

Colorectum